What We Test That Your Doctor Doesn't
Your doctor is good at what they do. That's not the issue. The issue is that what they do and what you need are two different things, and the gap between them is where your symptoms have been living.
Standard care is built around pathology. It's designed to detect disease states, treat acute conditions, and manage chronic illness once it's developed. It's excellent at what it's designed for. But it was never designed to optimize function in someone who isn't sick yet.
That's a different discipline entirely. And it requires a different set of tools.
The Standard Panel Problem
When your doctor orders a CBC and metabolic panel, they're running a screening tool. It's meant to flag problems that have already become significant. If your fasting glucose is high enough to qualify as diabetic, the test will catch it. If your LDL is elevated to a level that warrants medication, the test will catch it.
But what about the zone between optimal and pathological? What about the guy whose LDL looks fine but whose particle size and ApoB suggest a risk that the basic panel misses?
That zone is where most executives live. They're not sick enough to trigger concern on a standard panel, but they're not functioning at the level they should be. Their energy is off. Their cognition is off. Their performance in the bedroom is off. And every time they bring it up, they're told the labs look fine.
The labs do look fine, but they just aren't measuring the right things.
The Markers That Matter
There's a category of biomarkers that most doctors don't run because they're not part of the standard of care. These markers assess vascular efficiency, endothelial function, and the upstream factors that determine how well blood is actually getting where it needs to go.
Markers like ADMA, hs-CRP, and homocysteine can detect vascular dysfunction years before it shows up on a standard panel. They measure things like nitric oxide inhibition, systemic inflammation, and vascular toxicity. These aren't even exotic tests as they're available at most labs. They're just not part of what your insurance considers necessary, because the system is only built around intervention once things have already gone wrong.
How This Fits with Your Existing Care
This is more about filling the gap between what your doctor measures and what you need measured.
Your concierge physician or cardiologist handles disease prevention and management (incredibly well at that). They run imaging, stress tests, lipid panels, and prescribe medication when it's warranted. That's valuable, and you should keep doing it.
What we do is focus on the layer of vascular function that sits upstream of most of the symptoms you're experiencing. We measure the markers your doctor doesn't, and we build protocols designed to restore the function that standard interventions don't address.
Think of it as a complement. Your cardiologist makes sure you don't have a heart attack. We make sure your blood vessels are actually performing at the level your career demands.
Why This Matters Now
The longer vascular dysfunction progresses, the harder it becomes to reverse. Early intervention is easier and more effective. The 47-year-old with mild endothelial dysfunction responds better than the 57-year-old with entrenched inflammation and advanced glycocalyx degradation.
If you've been feeling off and your labs keep coming back normal, this is probably why. The tests you're getting aren't designed to catch what you're dealing with.
Understand the full framework — the specific markers we assess and how this fits with your existing care.
Read the Vascular Asset ReportBecause the answer to why you feel this way exists. It's just not showing up on the tests you've been running.
And once you see it, everything else starts to make sense.